Oventus

Oventus was an Australian medical device company focused on oral appliance therapy for obstructive sleep apnea, snoring, and related sleep-disordered breathing. Its core commercial products were the O2Vent family of custom oral devices, which used an airway channel design and were manufactured with digital workflows and 3D-printing-enabled production. The company commercialized these products in Australia, Canada, and the United States through dentist- and sleep-clinic-oriented models, including its "Lab in Lab" approach. Oventus entered administration in 2022, moved into liquidation in January 2023, and was delisted from the ASX in July 2023. Its business and assets were subsequently associated with Open Airway Dental Solutions, which appears to have continued commercializing the O2Vent product line.